Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in JapanTeppei Okamoto, Chikara Οhyama, Shingo Hatakeyama et al.|World Journal of Urology|2018Cited by 76
Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate CancerShusuke Akamatsu, Osamu Ogawa, Masashi Kubota et al.|European Urology Oncology|2018Cited by 55
Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patientsMasaki Shiota, Shintaro Narita, Hiroaki Yasumoto et al.|Cancer Science|2020Cited by 48
Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancerItsuto Hamano, Chikara Οhyama, Shingo Hatakeyama et al.|World Journal of Urology|2019Cited by 40
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in JapanShintaro Narita, Tomonori Habuchi, Shingo Hatakeyama et al.|International Journal of Clinical Oncology|2020Cited by 29